Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination

被引:347
|
作者
Sheaff, RJ
Singer, JD
Swanger, J
Smitherman, M
Roberts, JM
Clurman, BE
机构
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
[2] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA
[3] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA
[4] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98104 USA
[5] Univ Washington, Dept Med, Seattle, WA 98104 USA
[6] Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA
[7] Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA
关键词
D O I
10.1016/S1097-2765(00)80435-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Cdk inhibitor p21(Cip1) is an unstable protein. Pharmacologic inhibition of the proteasome increases the half-life of p21 from less than 30 min to more than 2 hr and results in the accumulation of p21-ubiquitin conjugates. To determine whether ubiquitination was required for proteasomal degradation of p21, we constructed mutant versions of p21 that were not ubiquitinated in vivo. Remarkably, these mutants remained unstable and increased in abundance upon proteasome inhibition, indicating that direct ubiquitination of p21 is not necessary for its turnover by the proteasome. The frequently observed correlation between protein ubiquitination and proteasomal degradation is insufficient to conclude that ubiquitination is a prerequisite for degradation.
引用
收藏
页码:403 / 410
页数:8
相关论文
共 50 条
  • [21] Regenerative response in ischemic brain restricted by p21cip1/waf1
    Qiu, JH
    Takagi, Y
    Harada, J
    Rodrigues, N
    Moskowitz, MA
    Scadden, DT
    Cheng, T
    JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (07): : 937 - 945
  • [22] Hematopoietic stem cell quiescence maintained by p21cip1/waf1
    Cheng, T
    Rodrigues, N
    Shen, HM
    Yang, YG
    Dombkowski, D
    Sykes, M
    Scadden, DT
    SCIENCE, 2000, 287 (5459) : 1804 - 1808
  • [23] Ubiquitylation and proteasomal degradation of the p21Cip1, p27Kip1 and p57Kip2 CDK inhibitors
    Lu, Zhimin
    Hunter, Tony
    CELL CYCLE, 2010, 9 (12) : 2342 - 2352
  • [24] Enhanced expansion capacity of endothelial progenitor cells in p21Cip1 -/- mice
    Bruhl, T
    Aicher, A
    Hoffmann, J
    Haendeler, J
    Schneider, MD
    Rossig, L
    CIRCULATION, 2002, 106 (19) : 143 - 143
  • [25] Less understood issues: p21Cip1 in mitosis and its therapeutic potential
    N-N Kreis
    F Louwen
    J Yuan
    Oncogene, 2015, 34 : 1758 - 1767
  • [26] Znhit1 Regulates p21Cip1 to Control Mouse Lens Differentiation
    Lu, Juan
    An, Jianhong
    Wang, Jiawei
    Cao, Xiaowen
    Cao, Yuqing
    Huang, Chengjie
    Jiao, Shiming
    Yan, Dongsheng
    Lin, Xinhua
    Zhou, Xiangtian
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (04)
  • [27] Regulation of p21Cip1/Waf1 mRNA and protein in cardiac myocytes
    Zoumpoulidou, G
    Kemp, T
    Aggeli, I
    Clerk, A
    HEART, 2006, 92 (02)
  • [28] Regulation of p21CIP1/WAF1 mRNA and protein in cardiac myocytes
    Zoumpoulidou, G
    Kemp, T
    Aggeli, I
    Clerk, A
    FEBS JOURNAL, 2005, 272 : 49 - 49
  • [29] Histone deacetylase inhibitors:: Signalling towards p21cip1/waf1
    Ocker, Matthias
    Schneider-Stock, Regine
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (7-8): : 1367 - 1374
  • [30] A study of survivin and p21cip1/waf1 expression in prostate cancer
    Thompson, MJ
    Ganta, S
    Seargent, J
    BRITISH JOURNAL OF CANCER, 2001, 85 : 87 - 87